Guided Therapeutics (GTHP) Other financing activities (2021 - 2025)

Guided Therapeutics has disclosed Other financing activities across 4 years of filings, most recently posting -$32000.0 for Q4 2025.

• Other financing activities for Q4 2025 came in at -$32000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was -$33000.0 (down 3200.0% YoY), and the FY2025 annual result was $30000.0, up 3.45% from the prior year.
• Other financing activities came in at -$32000.0 for Q4 2025 at Guided Therapeutics, down from -$31000.0 in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $722000.0 in Q3 2022 to a low of -$722000.0 in Q4 2022.
• The 4-year median for Other financing activities is -$500.0 (2024), against an average of $4833.3.
• Peak annual rise in Other financing activities reached 1064.52% in 2022, while the deepest fall reached 1064.52% in 2022.
• Guided Therapeutics' Other financing activities stood at $62000.0 in 2021, then tumbled by 1264.52% to -$722000.0 in 2022, then soared by 95.71% to -$31000.0 in 2024, then decreased by 3.23% to -$32000.0 in 2025.
• The last three Other financing activities figures came in at -$32000.0 (Q4 2025), -$31000.0 (Q3 2024), and $30000.0 (Q2 2024), per Business Quant data.